74 related articles for article (PubMed ID: 6883916)
1. Excretion of amines and their metabolites by two patients in hepatic coma treated with L-dopa.
Tyce GM; Stockard J; Sharpless NS; Muenter MD
Clin Pharmacol Ther; 1983 Sep; 34(3):390-8. PubMed ID: 6883916
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
Vasil'ev VN
Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-DOPA on the excretion of alcoholic metabolites of catecholamines and trace amines in rat and human urine.
Edwards DJ; Rizk M; Spiker DG
Biochem Med; 1981 Apr; 25(2):135-48. PubMed ID: 6169341
[No Abstract] [Full Text] [Related]
6. Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.
Faraj BA; Lawson DH; Nixon DW; Murray DR; Camp VM; Ali FM; Black M; Stacciarini W; Tarcan Y
Clin Chem; 1981 Jan; 27(1):108-12. PubMed ID: 7004664
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.
Andersen AD; Blaabjerg M; Binzer M; Kamal A; Thagesen H; Kjaer TW; Stenager E; Gramsbergen JBP
J Neurochem; 2017 May; 141(4):614-625. PubMed ID: 28244186
[TBL] [Abstract][Full Text] [Related]
8. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.
Andrew R; Watson DG; Best SA; Midgley JM; Wenlong H; Petty RK
Neurochem Res; 1993 Nov; 18(11):1175-7. PubMed ID: 8255370
[TBL] [Abstract][Full Text] [Related]
9. L-Dopa uptake and dopamine production in proximal tubular cells are regulated by beta(2)-adrenergic receptors.
Carranza A; Nowicki S; Barontini M; Armando I
Am J Physiol Renal Physiol; 2000 Jul; 279(1):F77-83. PubMed ID: 10894789
[TBL] [Abstract][Full Text] [Related]
10. Reversal of ammonia coma in rats by L-dopa: a peripheral effect.
Zieve L; Doizaki WM; Derr RF
Gut; 1979 Jan; 20(1):28-32. PubMed ID: 761833
[TBL] [Abstract][Full Text] [Related]
11. L-dopa in hepatic coma.
Fischer JE; Funovics FJ; Falcao HA; Wesdorp RI
Ann Surg; 1976 Apr; 183(4):386-91. PubMed ID: 1267495
[TBL] [Abstract][Full Text] [Related]
12. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acute hepatic encephalopathy with L-dopa.
Chajek T; Berry EM; Friedman G; Abramsky O
Postgrad Med J; 1977 May; 53(619):262-5. PubMed ID: 876934
[TBL] [Abstract][Full Text] [Related]
14. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
Vasil'ev VN; Matlina ESh
Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
[TBL] [Abstract][Full Text] [Related]
15. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
[TBL] [Abstract][Full Text] [Related]
16. [Long-term l-DOPA therapy for parkinsonism and its pathochemical aspect].
Petelin LS; Vartanian KZ; Romenskaia LKh
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(12):1810-3. PubMed ID: 602554
[TBL] [Abstract][Full Text] [Related]
17. Distribution of catecholamines between fetal and maternal compartments during human pregnancy with emphasis on L-dopa and dopamine.
Peleg D; Munsick RA; Diker D; Goldman JA; Ben-Jonathan N
J Clin Endocrinol Metab; 1986 May; 62(5):911-4. PubMed ID: 3958127
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 3, 4-dihydroxyphenylalanine, its metabolites and analogues in vivo in the rat: urinary excretion pattern.
Goodwin BL; Ruthven CR; King GS; Sandler M
Xenobiotica; 1978 Oct; 8(10):629-51. PubMed ID: 716472
[TBL] [Abstract][Full Text] [Related]
19. Trace amines in hepatic encephalopathy.
Mousseau DD; Butterworth RF
Prog Brain Res; 1995; 106():277-84. PubMed ID: 8584664
[TBL] [Abstract][Full Text] [Related]
20. [Reactivity of the DOPA--dopamine--noradrenaline--adrenaline system in epileptics].
Karlov VA; Gleĭzer MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):810-5. PubMed ID: 6410626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
